June 30, 2023 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted nearly 8,000 physicians, technologists, pharmacists, laboratory professionals, scientists and others at its 2023 Annual Meeting, themed “Eye on the Patient,” held in Chicago, Illinois. 

June 30, 2023 — Assistance from an artificial intelligence (AI) algorithm with high diagnostic accuracy improved radiologist performance in detecting lung cancers on chest X-rays and increased human acceptance

June 30, 2023 — Over 18 million people in the US who have been diagnosed with cancer are cancer survivors, according to the National Cancer Institute. While some survivors have experienced the relief of completing active cancer treatment, they may now face new hurdles in the next phase of their cancer journey. 

June 29, 2023 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced highlights from early clinical and preclinical studies of 177Lu-rhPSMA-10.1 by

June 29, 2023 — At the 2023 Annual Meeting of the Society of Nuclear Medicine & Molecular Imaging (SNMMI), June 24-27 at McCormick Place in Chicago, Siemens Healthineers debuted the Biograph Vision.X¹, a next-generation positron emission tomography/computed tomography (PET/CT) scanne

June 29, 2023 — Research presented at the 2023 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, SNMMI 2023, held in Chicago this week, showed a new computational technique — one which combines genomic and tau PET imaging data — promises a more personalized approach

June 29, 2023 — A study presented this week during the 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, SNMMI 2023, found that personalized dosing of men with prostate cancer resulted in improved patient outcomes.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now